CN105461674B - 1(r)-(4-羟基苯)-5(s)-苯基四氢吡喃及其制备方法和作为制备防治肿瘤药物的应用 - Google Patents
1(r)-(4-羟基苯)-5(s)-苯基四氢吡喃及其制备方法和作为制备防治肿瘤药物的应用 Download PDFInfo
- Publication number
- CN105461674B CN105461674B CN201511015311.6A CN201511015311A CN105461674B CN 105461674 B CN105461674 B CN 105461674B CN 201511015311 A CN201511015311 A CN 201511015311A CN 105461674 B CN105461674 B CN 105461674B
- Authority
- CN
- China
- Prior art keywords
- methanol
- mixed liquor
- volume ratio
- mixed
- dichloromethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 30
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 230000002265 prevention Effects 0.000 claims abstract description 25
- 208000019065 cervical carcinoma Diseases 0.000 claims abstract description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 225
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 138
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 56
- 239000000284 extract Substances 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 25
- 238000000605 extraction Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000003480 eluent Substances 0.000 claims description 12
- 238000010828 elution Methods 0.000 claims description 12
- 238000010829 isocratic elution Methods 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 11
- 238000010898 silica gel chromatography Methods 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- 239000003208 petroleum Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 201000011510 cancer Diseases 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000004007 reversed phase HPLC Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims 1
- 206010041823 squamous cell carcinoma Diseases 0.000 abstract description 15
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical class OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 210000004881 tumor cell Anatomy 0.000 abstract description 3
- -1 diphenyl pentane class compound Chemical class 0.000 abstract description 2
- HWEZWCGDAIOGRO-NSHDSACASA-N (2S)-2-phenyl-2H-pyran Chemical compound C1(=CC=CC=C1)[C@H]1OC=CC=C1 HWEZWCGDAIOGRO-NSHDSACASA-N 0.000 abstract 2
- 239000000243 solution Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 229940009456 adriamycin Drugs 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 240000003211 Corylus maxima Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001263603 Stellera Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical class ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000005204 hydroxybenzenes Chemical class 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 150000004880 oxines Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511015311.6A CN105461674B (zh) | 2015-12-31 | 2015-12-31 | 1(r)-(4-羟基苯)-5(s)-苯基四氢吡喃及其制备方法和作为制备防治肿瘤药物的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511015311.6A CN105461674B (zh) | 2015-12-31 | 2015-12-31 | 1(r)-(4-羟基苯)-5(s)-苯基四氢吡喃及其制备方法和作为制备防治肿瘤药物的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105461674A CN105461674A (zh) | 2016-04-06 |
CN105461674B true CN105461674B (zh) | 2018-11-02 |
Family
ID=55599890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511015311.6A Active CN105461674B (zh) | 2015-12-31 | 2015-12-31 | 1(r)-(4-羟基苯)-5(s)-苯基四氢吡喃及其制备方法和作为制备防治肿瘤药物的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105461674B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113861126B (zh) * | 2021-09-08 | 2024-03-12 | 新疆维吾尔自治区中药民族药研究所 | 高度氧化二萜及其制备方法和作为制备预防或/和治疗炎症的抗炎、抗菌药物中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1142495A (zh) * | 1996-06-28 | 1997-02-12 | 中国人民解放军第二军医大学 | 一种新型血小板激活因子拮抗剂及其制备方法 |
US20060276536A1 (en) * | 2004-02-12 | 2006-12-07 | Vander Jagt David L | Cancer treatment using curcumin derivatives |
WO2011022502A1 (en) * | 2009-08-18 | 2011-02-24 | Georgetown University | Boronic acid compositions and methods related to cancer |
-
2015
- 2015-12-31 CN CN201511015311.6A patent/CN105461674B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1142495A (zh) * | 1996-06-28 | 1997-02-12 | 中国人民解放军第二军医大学 | 一种新型血小板激活因子拮抗剂及其制备方法 |
US20060276536A1 (en) * | 2004-02-12 | 2006-12-07 | Vander Jagt David L | Cancer treatment using curcumin derivatives |
WO2011022502A1 (en) * | 2009-08-18 | 2011-02-24 | Georgetown University | Boronic acid compositions and methods related to cancer |
Also Published As
Publication number | Publication date |
---|---|
CN105461674A (zh) | 2016-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105017357A (zh) | 多酚黄酮类化合物及其制备方法和应用 | |
CN104586945B (zh) | 啤酒花总黄酮提取物、制备方法及其作为制备预防和治疗肝损伤、癌症药物的应用 | |
CN108003214A (zh) | 一种从土贝母中提取的皂苷化合物及其方法和应用 | |
CN105461674B (zh) | 1(r)-(4-羟基苯)-5(s)-苯基四氢吡喃及其制备方法和作为制备防治肿瘤药物的应用 | |
CN106083556B (zh) | 马齿苋中甘菊蓝结构化合物及其提取分离方法 | |
CN106045819B (zh) | 一种云实三环二萜及其制法和用途 | |
CN108503521A (zh) | 愈创木烷型倍半萜a及其制备方法和作为制备预防肿瘤和抗肿瘤药物的应用 | |
CN101284835B (zh) | 双倍半萜内酯类化合物及其制备方法和应用 | |
CN109942481A (zh) | 马齿苋中化合物Oleraisoindole A及其提取分离方法与应用 | |
CN101318946B (zh) | 化合物二聚兔耳风萜a及其制备方法和应用 | |
CN109369399A (zh) | 1,3-o-二阿魏酸酯-2-甲氧基丙二醇及其制备方法和应用 | |
CN105503541B (zh) | 1(s)‑(4‑羟基苯)‑5‑苯基‑1‑戊醇及其制备方法和作为制备防治肿瘤药物的应用 | |
CN107226820A (zh) | 一种具有抗肿瘤作用的毛菌素j及其制备方法与用途 | |
CN103183597A (zh) | 一种具有抗肿瘤活性的二芳基庚酮类化合物的制备和用途 | |
CN106317155A (zh) | 一种还原性葫芦烷型三萜及其制法和用途 | |
CN106045951B (zh) | 一种云实内酯及其制法和用途 | |
CN105669626A (zh) | 一种基于多溶剂制备川陈皮素的工艺 | |
CN101245048A (zh) | 一种抗肿瘤化合物红波罗花碱a及其制备方法和应用 | |
CN105669692B (zh) | 一种苯酞类二聚体化合物的提取方法和用途 | |
CN109651233A (zh) | 一种生物碱类化合物及其从棒节石斛中提取分离的方法与应用 | |
CN101318966B (zh) | 二聚倍半萜类化合物及其制备方法和应用 | |
CN109053641A (zh) | 一种二新木脂素类化合物及分离制备方法和应用 | |
CN101284833B (zh) | 化合物双旋覆花内酯丁及其制备方法和应用 | |
CN109206392A (zh) | 一种香豆素类化合物及其制备方法与应用 | |
CN106966969B (zh) | 一种生物碱化合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No. 9, Xinmin Road, Tianshan District, Urumqi, the Xinjiang Uygur Autonomous Region Applicant after: Xinjing Vygur Autonomous Region Chinese Medicine and Ethnic Medicine Research In Address before: No. 9, Xinmin Road, Shuimogou District, Urumqi, the Xinjiang Uygur Autonomous Region Applicant before: Xinjing Vygur Autonomous Region Chinese Medicine and Ethnic Medicine Research In |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210729 Address after: 830023 No. 61, shaping West Street, industrial park, Toutunhe District, Urumqi City, Xinjiang Uygur Autonomous Region Patentee after: XINJIANG BIOCHEMICAL PHARMACEUTICAL Co.,Ltd. Address before: 830002 No.9 Xinmin Road, Tianshan District, Urumqi, Xinjiang Uygur Autonomous Region Patentee before: Xinjiang Uygur Autonomous Region Institute of traditional Chinese Medicine |